摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R) ethyl 5-methyl-3-bromo-hexanoate | 1166864-51-2

中文名称
——
中文别名
——
英文名称
(R) ethyl 5-methyl-3-bromo-hexanoate
英文别名
(+/-) ethyl 5-methyl-3-bromo-hexanoate;Ethyl 5-methyl-3-bromo-hexanoate;ethyl 3-bromo-5-methylhexanoate
(R) ethyl 5-methyl-3-bromo-hexanoate化学式
CAS
1166864-51-2
化学式
C9H17BrO2
mdl
——
分子量
237.137
InChiKey
IBMYSFUJRKIQAJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    12
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    硝基甲烷(R) ethyl 5-methyl-3-bromo-hexanoate1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以96%的产率得到5-甲基-3-(硝基甲基)己酸乙酯
    参考文献:
    名称:
    PROCESS TO PREGABALIN
    摘要:
    本发明涉及一种新的方法,用于制备外消旋的pregabalin(1)或其单一对映体(S)-(+)-3-(氨甲基)-5-甲基-己酸(2)。
    公开号:
    US20100324139A1
  • 作为产物:
    描述:
    ethyl 3-hydroxy-5-methyl-hexanoate三苯基膦 作用下, 以 二氯甲烷 为溶剂, 以70%的产率得到(R) ethyl 5-methyl-3-bromo-hexanoate
    参考文献:
    名称:
    PROCESS TO PREGABALIN
    摘要:
    本发明涉及一种新的方法,用于制备外消旋的pregabalin(1)或其单一对映体(S)-(+)-3-(氨甲基)-5-甲基-己酸(2)。
    公开号:
    US20100324139A1
点击查看最新优质反应信息

文献信息

  • [EN] PROCESSES TO PREGABALIN<br/>[FR] PROCÉDÉS DE PRÉPARATION DE LA PRÉGABALINE
    申请人:GENERICS UK LTD
    公开号:WO2009081208A1
    公开(公告)日:2009-07-02
    The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2).
    本发明涉及一种新颖的方法,用于制备外消旋的pregabalin(1)或其单一对映体(S)-(+)-3-(氨甲基)-5-甲基-己酸(2)。
  • PROCESSES TO PREGABALIN
    申请人:Generics (UK) Limited
    公开号:EP2222630A1
    公开(公告)日:2010-09-01
  • [EN] A PROCESS FOR THE PREPARATION OF PREGABALIN<br/>[FR] PROCÉDÉ DE PRÉPARATION DE PRÉGABALINE
    申请人:HIKAL LTD
    公开号:WO2014072785A2
    公开(公告)日:2014-05-15
    The present invention provides an improved process for the preparation of a compound of formula (I), which comprises the steps of: formula (I), (a) reacting isovaleraldehyde of formula (II) and alkyl cyanoacetate of formula (III) optionally in presence of salts of weak acid and weak base or weak base in a suitable solvent to get 2-cyano-5- methyl-hex-2-enoic acid alkyl ester of formula (IV); (b) reacting 2-cyano-5-methyl-hex-2-enoic acid alkyl ester of formula (IV) with a suitable cyanide source in water or in an organic solvent or mixture thereof to get 2-isobutylsuccinonitrile of formula (V); (c) obtaining optionally 2-isobutylsuccinonitrile of formula (V) by reacting isovaleraldehyde of formula (II) and alkyl cyanoacetate of formula (III) in presence of suitable cyanide source in water or in an organic solvent or mixture thereof in single step; (d) converting 2-isobutylsuccinonitrile of formula (V) to racemic 3-cyano-5-methyl-hexanoic acid or salt thereof of formula (VI) with a genetically modified nitrilase enzyme (Nit 9N_56_2) in water or optionally with an organic co-solvent at appropriate pH and temperature; (e) converting racemic 3-cyano-5-methyl-hexanoic acid or salt thereof of formula (VI) to racemic alkyl 3-cyano-5-methyl-hexanoate of formula (VII) by treatment with alcohol (R3OH) and acidic catalyst or alkyl halide (R3X) in presence of a base in a suitable solvent or a mixture of solvents thereof;.(f) obtaining (S)-alkyl 3 -cyano-5 -methyl -hexanoate of formula (VIII) and (R)-3-cyano-5-methyl- hexanoic acid or salt thereof of formula (X) by enzymatic enantioselective hydrolysis in water or organic solvent or a mixture thereof from racemic alkyl 3-cyano-5-methyl-hexanoate of formula (VII);.(g) obtaining optionally the compound of formula (VII) by racemizing unwanted (R)-3-cyano-5- methyl-hexanoic acid or salt thereof of formula (X) or substantially enriched (R)-3 -cyano-5 - methyl-hexanoic acid salt thereof of formula (X) in presence of a base in organic solvent or a mixture thereof; (h) converting (S)-alkyl 3-cyano-5-methyl-hexanoate of formula (VIII) to pregabalin of formula (I) by hydrolyzing ester group with suitable alkali or alkaline earth metal base followed by hydrogenation optionally in one pot in a solvent selected from water or other organic solvents or a mixture thereof in presence of a suitable hydrogenation catalyst.
  • PROCESS TO PREGABALIN
    申请人:Gaitonde Abhay
    公开号:US20100324139A1
    公开(公告)日:2010-12-23
    The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2).
    本发明涉及一种新的方法,用于制备外消旋的pregabalin(1)或其单一对映体(S)-(+)-3-(氨甲基)-5-甲基-己酸(2)。
查看更多